They're also leveraging the very thing that was intended to keep pharmaceuticals a legitimate industry; the FDA. The drug he (and many companies) target are drugs where the patent has expired but there is no FDA approved generic. I believe FDA approval can take up to 5 years, so that's 5 years it takes for the market to react. Of course in a free market, this would never happen because 10 other companies would start making the drug, but the FDA safeguards are being leveraged against fair competition.

Not only are these companies jacking up prices with monopolistic practices, but they are eroding the legitimacy of the FDA (also to their benefit).

> Cornering a drug and hiking the price simply for profit and no other legitimate reason (supply chain issue, newer/more effective version, etc...) should be illegal.

This is how all patents work. Are you against patents?

Daraprim is not patented.